Intuitive Surgical, Inc. $ISRG Stock Position Lowered by Willner & Heller LLC

Willner & Heller LLC cut its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.9% during the second quarter, HoldingsChannel.com reports. The fund owned 3,436 shares of the medical equipment provider’s stock after selling 217 shares during the quarter. Intuitive Surgical makes up approximately 1.6% of Willner & Heller LLC’s investment portfolio, making the stock its 10th biggest holding. Willner & Heller LLC’s holdings in Intuitive Surgical were worth $1,867,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of the stock. Chilton Capital Management LLC increased its holdings in Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 43 shares during the period. Elite Financial Inc. purchased a new position in Intuitive Surgical during the first quarter valued at approximately $26,000. LFA Lugano Financial Advisors SA purchased a new position in Intuitive Surgical during the first quarter valued at approximately $30,000. TD Capital Management LLC increased its holdings in Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 45 shares during the period. Finally, 1248 Management LLC purchased a new position in Intuitive Surgical during the first quarter valued at approximately $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $452.35 on Friday. The stock has a market capitalization of $162.16 billion, a P/E ratio of 63.09, a PEG ratio of 4.64 and a beta of 1.61. The company has a 50 day moving average price of $463.55 and a 200 day moving average price of $500.00. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. During the same period in the prior year, the business earned $1.78 EPS. The firm’s quarterly revenue was up 21.4% on a year-over-year basis. Research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research firms have issued reports on ISRG. The Goldman Sachs Group cut their price target on shares of Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating on the stock in a report on Wednesday. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $615.00 price target on shares of Intuitive Surgical in a report on Tuesday, August 19th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Intuitive Surgical in a report on Saturday, September 27th. Truist Financial lifted their price target on shares of Intuitive Surgical from $590.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 23rd. Finally, Erste Group Bank reiterated a “hold” rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Fourteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $594.19.

Insider Buying and Selling

In related news, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the sale, the executive vice president directly owned 353 shares in the company, valued at $173,845.44. This trade represents a 92.73% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Amy L. Ladd sold 335 shares of Intuitive Surgical stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $440.69, for a total transaction of $147,631.15. Following the completion of the sale, the director directly owned 739 shares in the company, valued at approximately $325,669.91. The trade was a 31.19% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 45,224 shares of company stock worth $21,716,492 in the last ninety days. 0.70% of the stock is owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.